Gelteq Limited Ordinary Shares (GELS)

FairStock Score: 45/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Gelteq with Graham's caution and Buffett's preference for understandable, durable businesses. Gelteq sells white-label gel delivery systems—edible gels for prescription drugs, nutraceuticals, pet care, and sports or over-the-counter products—from a seven-employee base. That is a thin operation, not a proven franchise. No revenue growth, profit growth, or dividend figures were provided, and FairStock's Lynch screen assigns no category because only zero years of filed results exist; it wants three. That absence of history matters more than any single ratio.

In plain English: Gelteq makes gel-based delivery products, such as edible gels for medicines, pet care, and sports products, and it has only seven employees. The business looks weak right now: it is losing money, shows several signs of financial strain, and has almost no reported operating history. The stock price looks cheap compared with the company's accounting net worth, but that may simply reflect the losses and high uncertainty.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer